{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:24:01Z","timestamp":1793496241500,"version":"4.5.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:title>ABSTRACT:<\/jats:title>\n          <jats:p>The pelvic examination has long been considered a fundamental component of the well-woman visit, and many women and gynecologic care providers view this visit as an opportunity to discuss sexual and reproductive health issues. Traditionally, a pelvic examination is performed for asymptomatic women as a screening tool for gynecologic cancer, infection, and asymptomatic pelvic inflammatory disease; some obstetrician\u2013gynecologists and patients consider it important in detecting subclinical disease, despite evidence to the contrary. Given changes in screening recommendations and the ability to screen for sexually transmitted infections using less-invasive methods, reevaluation of the role of the pelvic examination for asymptomatic, nonpregnant women is warranted. A limited number of studies have evaluated the benefits and harms of a screening pelvic examination for detection of ovarian cancer, bacterial vaginosis, trichomoniasis, and genital herpes. Data from these studies are inadequate to support a recommendation for or against performing a routine screening pelvic examination among asymptomatic, nonpregnant women who are not at increased risk of any specific gynecologic condition. It is recommended by the American College of Obstetricians and Gynecologists that pelvic examinations be performed when indicated by medical history or symptoms. Women with current or a history of cervical dysplasia, gynecologic malignancy, or in utero diethylstilbestrol exposure should be screened and managed according to guidelines specific to those gynecologic conditions. Based on the current limited data on potential benefits and harms and expert opinion, the decision to perform a pelvic examination should be a shared decision between the patient and her obstetrician\u2013gynecologist or other gynecologic care provider.<\/jats:p>","DOI":"10.1097\/aog.0000000000002895","type":"journal-article","created":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T20:27:44Z","timestamp":1537993664000},"page":"e174-e180","source":"Crossref","is-referenced-by-count":65,"title":["ACOG Committee Opinion No. 754: The Utility of and Indications for Routine Pelvic Examination"],"prefix":"10.1097","volume":"132","member":"276","reference":[{"key":"R2-20230711","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/jama.2017.0807","article-title":"Screening for gynecologic conditions with pelvic examination: US Preventive Services Task Force Recommendation Statement. US Preventive Services Task Force","volume":"317","author":"Bibbins-Domingo","year":"2017","journal-title":"JAMA"},{"key":"R3-20230711","first-page":"8","article-title":"The annual pelvic examination: preventive time not well spent","volume":"87","author":"Nguyen","year":"2013","journal-title":"Am Fam Physician"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"67","DOI":"10.7326\/M14-0701","article-title":"Screening pelvic examination in adult women: a clinical practice guideline from the American College of Physicians. Clinical Guidelines Committee of the American College of Physicians","volume":"161","author":"Qaseem","year":"2014","journal-title":"Ann Intern Med"},{"key":"R5-20230711","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1001\/archinte.165.12.1347","article-title":"Support of evidence-based guidelines for the annual physical examination: a survey of primary care providers","volume":"165","author":"Prochazka","year":"2005","journal-title":"Arch Intern Med"},{"key":"R6-20230711","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/jwh.2010.2349","article-title":"Do new guidelines and technology make the routine pelvic examination obsolete?","volume":"20","author":"Westhoff","year":"2011","journal-title":"J Womens Health (Larchmt)"},{"issue":"RR-03","key":"R7-20230711","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015. Centers for Disease Control and Prevention [published erratum appears in MMWR Recomm Rep 2015;64:924]","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR Recomm Rep"},{"key":"R8-20230711","doi-asserted-by":"crossref","first-page":"109.e1","DOI":"10.1016\/j.ajog.2012.11.015","article-title":"Routine bimanual pelvic examinations: practices and beliefs of US obstetrician\u2013gynecologists","volume":"208","author":"Henderson","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1001\/jama.2016.12819","article-title":"Periodic screening pelvic examination: evidence report and systematic review for the US Preventive Services Task Force","volume":"317","author":"Guirguis-Blake","year":"2017","journal-title":"JAMA"},{"key":"R10-20230711","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1001\/jama.2011.766","article-title":"Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. PLCO Project Team","volume":"305","author":"Buys","year":"2011","journal-title":"JAMA"},{"key":"R11-20230711","doi-asserted-by":"crossref","first-page":"46","DOI":"10.7326\/M13-2881","article-title":"Screening pelvic examinations in asymptomatic, average-risk adult women: an evidence report for a clinical practice guideline from the American College of Physicians","volume":"161","author":"Bloomfield","year":"2014","journal-title":"Ann Intern Med"},{"key":"R12-20230711","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1097\/AOG.0000000000002897","article-title":"Well-Woman Visit. Committee Opinion No. 755. American College of Obstetricians and Gynecologists","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R13-20230711","doi-asserted-by":"crossref","first-page":"86.e1","DOI":"10.1016\/j.ajog.2016.12.031","article-title":"Women's beliefs about the purpose and value of routine pelvic examinations","volume":"217","author":"Norrell","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R14-20230711","doi-asserted-by":"crossref","first-page":"338.e1","DOI":"10.1016\/j.ajog.2017.05.003","article-title":"Effect of professional society recommendations on women\u2019s desire for a routine pelvic examination","volume":"217","author":"Sawaya","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R15-20230711","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/LGT.0b013e318287d329","article-title":"2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. 2012 ASCCP Consensus Guidelines Conference [published erratum appears in J Low Genit Tract Dis 2013;17:367]","volume":"17","author":"Massad","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"R16-20230711","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1097\/01.AOG.0000438960.31355.9e","article-title":"Management of abnormal cervical cancer screening test results and cervical cancer precursors. Practice Bulletin No. 140. American College of Obstetricians and Gynecologists","volume":"122","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R17-20230711","first-page":"e111","article-title":"Cervical cancer screening and prevention. Practice Bulletin No. 168. American College of Obstetricians and Gynecologists","volume":"128","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R20-20230711","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/01.AOG.0000443279.14017.12","article-title":"Effective patient\u2013physician communication. Committee Opinion No. 587. American College of Obstetricians and Gynecologists","volume":"123","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R21-20230711","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1097\/AOG.0b013e31821d7d60","article-title":"Partnering with patients to improve safety. Committee Opinion No. 490. American College of Obstetricians and Gynecologists","volume":"117","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R23-20230711","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.contraception.2005.10.008","article-title":"New recommendations for the periodic well-woman visit: impact on counseling","volume":"73","author":"Shulman","year":"2006","journal-title":"Contraception"},{"issue":"RR-3","key":"R24-20230711","first-page":"1","article-title":"U.S. medical eligibility criteria for contraceptive use, 2016","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"issue":"RR-2","key":"R25-20230711","first-page":"1","article-title":"Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae\u20142014. Centers for Disease Control and Prevention","volume":"63","year":"2014","journal-title":"MMWR Recomm Rep"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201810000-00060","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T19:17:57Z","timestamp":1689103077000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201810000-00060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000002895","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]}}}